“We are pleased to see the excellent quality of our product confirmed once again with the successful MDR certification, thus maintaining its validity beyond the MDD certificate. And we are excited that we can now focus on opening up new markets for our ECLS product abroad,” said Dr. Jürgen O. Böhm, CEO & CMO of Hemovent GmbH.

The MOBYBOX™ is the first ECLS device that uses only pneumatic power as its energy source and integrates both blood flow control and gas management into a single device. It does not require complex software and it weighs only 2 kg. The innovative Bionique Flow Technology provides gentle treatment of blood and is unique in ECLS application. So it is not surprising that Hemovent, with its MOBYBOX™, was crowned the winner of the Aachen Innovation Award in 2021. “We are very proud of our successes to date and of our staff, who made all this possible in the first place. It is great to see everyone working towards a joint goal. At the moment, we are concentrating on expanding our portfolio and internationalizing our products. And thanks to our strong team, I am absolutely confident that we will continue to successfully accomplish the upcoming projects,” continued Dr. Böhm.